Successful management of post-COVID-19 acanthamoebic encephalitis

Acanthamoebic encephalitis is a rare and highly fatal disease that has no standard management protocol. Coronavirus disease 2019 (COVID-19) causes immune dysfunction and may predispose patients to this infection. The present study describes successful management of acanthamoebic encephalitis in a yo...

Descripción completa

Detalles Bibliográficos
Autores principales: Siripurapu, Govinda, Samad, Sameer Abdul, Fatima, Saman, Wig, Naveet, Srivastava, M.V. Padma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295052/
https://www.ncbi.nlm.nih.gov/pubmed/34302963
http://dx.doi.org/10.1016/j.ijid.2021.07.046
Descripción
Sumario:Acanthamoebic encephalitis is a rare and highly fatal disease that has no standard management protocol. Coronavirus disease 2019 (COVID-19) causes immune dysfunction and may predispose patients to this infection. The present study describes successful management of acanthamoebic encephalitis in a young male who recently recovered from COVID-19 using a combination of medical and surgical approaches. A combination of miltefosine with other agents with trophicidal and cysticidal activities should be used in the regimen. Surgical excision of the abscess should be undertaken whenever feasible.

Ejemplares similares